Literature DB >> 22263840

Fibrin specific peptides derived by phage display: characterization of peptides and conjugates for imaging.

Andrew F Kolodziej1, Shrikumar A Nair, Philip Graham, Thomas J McMurry, Robert C Ladner, Charles Wescott, Daniel J Sexton, Peter Caravan.   

Abstract

Peptides that bind to fibrin but not to fibrinogen or serum albumin were selected from phage display libraries as targeting moieties for thrombus molecular imaging probes. Three classes of cyclic peptides (cyclized via disulfide bond between two Cys) were identified with consensus sequences XArXCPY(G/D)LCArIX (Ar = aromatic, Tn6), X(2)CXYYGTCLX (Tn7), and NHGCYNSYGVPYCDYS (Tn10). These peptides bound to fibrin at ∼2 sites with K(d) = 4.1 μM, 4.0 μM, and 8.7 μM, respectively, whereas binding to fibrinogen was at least 100-fold weaker. The peptides also bind to the fibrin degradation product DD(E) with similar affinity to that measured for fibrin. The Tn7 and Tn10 peptides bind to the same site on fibrin, while the Tn6 peptides bind to a unique site. Alanine scanning identified the N- and C-terminal ends of the Tn6 and Tn7 peptides as most tolerant to modification. Peptide conjugates with either fluorescein or diethylenetriaminepentaaceto gadolinium(III) (GdDTPA) at the N-terminus were prepared for potential imaging applications, and these retained fibrin binding affinity and specificity in plasma. Relaxivity and binding studies on the GdDTPA derivatives revealed that an N-terminal glycyl linker had a modest effect on fibrin affinity but resulted in lower fibrin-bound relaxivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22263840      PMCID: PMC3310290          DOI: 10.1021/bc200613e

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  32 in total

1.  Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.

Authors:  S Yakovlev; E Makogonenko; N Kurochkina; W Nieuwenhuizen; K Ingham; L Medved
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

2.  Screening for fibrin specific monoclonal antibodies: the development of a new procedure.

Authors:  P M Tymkewycz; L J Creighton-Kempsford; D Hockley; P J Gaffney
Journal:  Thromb Haemost       Date:  1992-07-06       Impact factor: 5.249

3.  Fibrin assembly.

Authors:  R Hantgan; J McDonagh; J Hermans
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

4.  Molecular MRI of intracranial thrombus in a rat ischemic stroke model.

Authors:  Ritika Uppal; Ilknur Ay; Guangping Dai; Young Ro Kim; A Gregory Sorensen; Peter Caravan
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

5.  Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands.

Authors:  S Feng; C Kasahara; R J Rickles; S L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.

Authors:  Elmar Spuentrup; Marcus Katoh; Andrea J Wiethoff; Edward C Parsons; Rene M Botnar; Andreas H Mahnken; Rolf W Günther; Arno Buecker
Journal:  Am J Respir Crit Care Med       Date:  2005-06-03       Impact factor: 21.405

7.  Development of mammalian serum albumin affinity purification media by peptide phage display.

Authors:  Aaron K Sato; Daniel J Sexton; Lee A Morganelli; Edward H Cohen; Qi Long Wu; Greg P Conley; Zoya Streltsova; Stan W Lee; Mary Devlin; Daniel B DeOliveira; Jasmin Enright; Rachel B Kent; Charles R Wescott; Tom C Ransohoff; Arthur C Ley; Robert C Ladner
Journal:  Biotechnol Prog       Date:  2002 Mar-Apr

8.  Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse.

Authors:  Shahrokh Falati; Peter Gross; Glenn Merrill-Skoloff; Barbara C Furie; Bruce Furie
Journal:  Nat Med       Date:  2002-09-16       Impact factor: 53.440

9.  MR imaging of thrombi using EP-2104R, a fibrin-specific contrast agent: initial results in patients.

Authors:  Elmar Spuentrup; Rene M Botnar; Andrea J Wiethoff; Tareq Ibrahim; Sebastian Kelle; Marcus Katoh; Murat Ozgun; Eike Nagel; Josef Vymazal; Phil B Graham; Rolf W Günther; David Maintz
Journal:  Eur Radiol       Date:  2008-04-19       Impact factor: 5.315

10.  Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.

Authors:  Josef Vymazal; Elmar Spuentrup; Gerardo Cardenas-Molina; Andrea J Wiethoff; Michael G Hartmann; Peter Caravan; Edward C Parsons
Journal:  Invest Radiol       Date:  2009-11       Impact factor: 6.016

View more
  34 in total

1.  Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-08-13       Impact factor: 8.311

Review 2.  Bioengineered probes for molecular magnetic resonance imaging in the nervous system.

Authors:  Vivian Hsieh; Alan Jasanoff
Journal:  ACS Chem Neurosci       Date:  2012-07-11       Impact factor: 4.418

3.  Synthesis and Biological Evaluation of Cyclic [99mTc]-HYNIC-CGPRPPC as a Fibrin-Binding Peptide for Molecular Imaging of Thrombosis and Its Comparison with [99mTc]-HYNIC-GPRPP.

Authors:  Sedigheh Rezaeianpour; Atefeh Hajiagha Bozorgi; Abolghasem Moghimi; Ameneh Almasi; Saeed Balalaie; Sorour Ramezanpour; Sanaz Nasoohi; Seyed Mohammad Mazidi; Parham Geramifar; Ahmad Bitarafan-Rajabi; Soraya Shahhosseini
Journal:  Mol Imaging Biol       Date:  2017-04       Impact factor: 3.488

4.  Radiation Dosimetry of the Fibrin-Binding Probe ⁶⁴Cu-FBP8 and Its Feasibility for PET Imaging of Deep Vein Thrombosis and Pulmonary Embolism in Rats.

Authors:  Francesco Blasi; Bruno L Oliveira; Tyson A Rietz; Nicholas J Rotile; Helen Day; Pratap C Naha; David P Cormode; David Izquierdo-Garcia; Ciprian Catana; Peter Caravan
Journal:  J Nucl Med       Date:  2015-05-14       Impact factor: 10.057

Review 5.  What Is the Biological and Clinical Relevance of Fibrin?

Authors:  Rustem I Litvinov; John W Weisel
Journal:  Semin Thromb Hemost       Date:  2016-04-07       Impact factor: 4.180

6.  In vivo molecular imaging of thrombosis and thrombolysis using a fibrin-binding positron emission tomographic probe.

Authors:  Ilknur Ay; Francesco Blasi; Tyson A Rietz; Nicholas J Rotile; Sreekanth Kura; Anna Liisa Brownell; Helen Day; Bruno L Oliveira; Richard J Looby; Peter Caravan
Journal:  Circ Cardiovasc Imaging       Date:  2014-04-28       Impact factor: 7.792

7.  Fibrin-targeted PET probes for the detection of thrombi.

Authors:  Katie L Ciesienski; Yan Yang; Ilknur Ay; Daniel B Chonde; Galen S Loving; Tyson A Rietz; Ciprian Catana; Peter Caravan
Journal:  Mol Pharm       Date:  2013-01-30       Impact factor: 4.939

8.  A Fibrin Cross-linking Polymer Enhances Clot Formation Similar to Factor Concentrates and Tranexamic Acid in an in vitro Model of Coagulopathy.

Authors:  Leslie W Chan; Nathan J White; Suzie H Pun
Journal:  ACS Biomater Sci Eng       Date:  2016-01-28

Review 9.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

10.  Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.

Authors:  Eszter Boros; Elena Rybak-Akimova; Jason P Holland; Tyson Rietz; Nicholas Rotile; Francesco Blasi; Helen Day; Reza Latifi; Peter Caravan
Journal:  Mol Pharm       Date:  2013-12-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.